174 related articles for article (PubMed ID: 38008215)
1. Diversity of atopic dermatitis and selection of immune targets.
Rothenberg-Lausell C; Bar J; Del Duca E; Guttman-Yassky E
Ann Allergy Asthma Immunol; 2024 Feb; 132(2):177-186. PubMed ID: 38008215
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.
Suárez-Fariñas M; Dhingra N; Gittler J; Shemer A; Cardinale I; de Guzman Strong C; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2013 Aug; 132(2):361-70. PubMed ID: 23777851
[TBL] [Abstract][Full Text] [Related]
3. Atopic dermatitis in African American patients is T
Sanyal RD; Pavel AB; Glickman J; Chan TC; Zheng X; Zhang N; Cueto I; Peng X; Estrada Y; Fuentes-Duculan J; Alexis AF; Krueger JG; Guttman-Yassky E
Ann Allergy Asthma Immunol; 2019 Jan; 122(1):99-110.e6. PubMed ID: 30223113
[TBL] [Abstract][Full Text] [Related]
4. Endophenotypic Variations of Atopic Dermatitis by Age, Race, and Ethnicity.
Nomura T; Wu J; Kabashima K; Guttman-Yassky E
J Allergy Clin Immunol Pract; 2020 Jun; 8(6):1840-1852. PubMed ID: 32499033
[TBL] [Abstract][Full Text] [Related]
5. The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective.
David E; Ungar B; Renert-Yuval Y; Facheris P; Del Duca E; Guttman-Yassky E
Clin Exp Allergy; 2023 Feb; 53(2):156-172. PubMed ID: 36653940
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of biologics in atopic dermatitis.
Wu J; Guttman-Yassky E
Expert Opin Biol Ther; 2020 May; 20(5):525-538. PubMed ID: 32003247
[No Abstract] [Full Text] [Related]
7. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies.
Furue M; Chiba T; Tsuji G; Ulzii D; Kido-Nakahara M; Nakahara T; Kadono T
Allergol Int; 2017 Jul; 66(3):398-403. PubMed ID: 28057434
[TBL] [Abstract][Full Text] [Related]
8. Targeting cytokines and signaling molecules related to immune pathways in atopic dermatitis: therapeutic implications and challenges.
Kim HO
Arch Pharm Res; 2022 Dec; 45(12):894-908. PubMed ID: 36462097
[TBL] [Abstract][Full Text] [Related]
9. Atopic dermatitis in skin of colour. Part 1: new discoveries in epidemiology and pathogenesis.
Gan C; Mahil S; Pink A; Rodrigues M
Clin Exp Dermatol; 2023 Jun; 48(6):609-616. PubMed ID: 37002798
[TBL] [Abstract][Full Text] [Related]
10. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.
Noda S; Suárez-Fariñas M; Ungar B; Kim SJ; de Guzman Strong C; Xu H; Peng X; Estrada YD; Nakajima S; Honda T; Shin JU; Lee H; Krueger JG; Lee KH; Kabashima K; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Nov; 136(5):1254-64. PubMed ID: 26428954
[TBL] [Abstract][Full Text] [Related]
11.
Oh JS; Lee SJ; Choung SY
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579088
[TBL] [Abstract][Full Text] [Related]
12. Current and emerging biologic and small molecule therapies for atopic dermatitis.
Li R; Hadi S; Guttman-Yassky E
Expert Opin Biol Ther; 2019 Apr; 19(4):367-380. PubMed ID: 30672355
[TBL] [Abstract][Full Text] [Related]
13. Oral Janus kinase inhibitors for atopic dermatitis.
Mikhaylov D; Ungar B; Renert-Yuval Y; Guttman-Yassky E
Ann Allergy Asthma Immunol; 2023 May; 130(5):577-592. PubMed ID: 36736457
[TBL] [Abstract][Full Text] [Related]
14. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.
Brunner PM; Guttman-Yassky E; Leung DY
J Allergy Clin Immunol; 2017 Apr; 139(4S):S65-S76. PubMed ID: 28390479
[TBL] [Abstract][Full Text] [Related]
15. Early-onset pediatric atopic dermatitis is T
Esaki H; Brunner PM; Renert-Yuval Y; Czarnowicki T; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Johnson DB; Bauer B; Fuentes-Duculan J; Zheng X; Peng X; Estrada YD; Xu H; de Guzman Strong C; Suárez-Fariñas M; Krueger JG; Paller AS; Guttman-Yassky E
J Allergy Clin Immunol; 2016 Dec; 138(6):1639-1651. PubMed ID: 27671162
[TBL] [Abstract][Full Text] [Related]
16. Recent Advancements in the Atopic Dermatitis Mechanism.
Savva M; Papadopoulos NG; Gregoriou S; Katsarou S; Papapostolou N; Makris M; Xepapadaki P
Front Biosci (Landmark Ed); 2024 Feb; 29(2):84. PubMed ID: 38420827
[TBL] [Abstract][Full Text] [Related]
17. Atopic dermatitis endotypes and implications for targeted therapeutics.
Czarnowicki T; He H; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2019 Jan; 143(1):1-11. PubMed ID: 30612663
[TBL] [Abstract][Full Text] [Related]
18. Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis.
Pavel AB; Song T; Kim HJ; Del Duca E; Krueger JG; Dubin C; Peng X; Xu H; Zhang N; Estrada YD; Denis L; Rao N; Gupta S; Zammit DJ; Bissonnette R; Guttman-Yassky E
J Allergy Clin Immunol; 2019 Oct; 144(4):1011-1024. PubMed ID: 31356921
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and action mechanisms of a Chinese herbal formula on experimental models of atopic dermatitis.
Wang L; Xian YF; Hu Z; Loo SKF; Ip SP; Chan WY; Lin ZX; Wu JCY
J Ethnopharmacol; 2021 Jun; 274():114021. PubMed ID: 33716079
[TBL] [Abstract][Full Text] [Related]
20. Future treatment options for atopic dermatitis - small molecules and beyond.
Schäkel K; Döbel T; Bosselmann I
J Dermatol Sci; 2014 Feb; 73(2):91-100. PubMed ID: 24360854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
